HOBSCOTCH Program for Epilepsy

Recruiting in Palo Alto (17 mi)

Overseen by Barbara Jobst, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Dartmouth-Hitchcock Medical Center

No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to determine the efficacy of an entirely virtual version of the home-based cognitive self-management program "HOBSCOTCH." It will test whether HOBSCOTCH can be delivered nationally from a distance utilizing e-health tools (telephone, computer, and phone).

Eligibility Criteria

This trial is for adults over 18 with epilepsy who can read and have access to a phone and the internet. They should be on a stable medication regimen for at least one month, although brief stops for specific tests are okay. Participants must also have memory concerns but cannot have dementia, severe mental disability, significant visual impairments, or lack reliable communication tools.

Inclusion Criteria

I am 18 years old or older.

You need to have access to the internet.

Literate

Exclusion Criteria

No reliable telephone or internet access

Severe mental disability or estimated IQ less than 70 per clinical judgement

Subjects self-reporting a dementing illness or a mention of a dementing illness in their medical record

Participant Groups

The HOBSCOTCH Phase III trial is testing an entirely virtual cognitive self-management program designed to help people with epilepsy manage their condition from home using e-health tools like telephone and computer.

Group I: HOBSCOTCH-V (virtual) Experimental Treatment 1 Intervention

Participants will receive the HOBSCOTCH intervention consisting of 1:1 sessions delivered once per week, including: * 1 pre-HOBSCOTCH Session (on webcam) * 1 educational session (on webcam) * 6 telephone sessions * 1 wrap-up session (webcam or telephone) Participants will also receive 3 booster sessions, via webcam or telephone, once per month.

Group II: Control Experimental Treatment 1 Intervention

Participants will be wait listed and will receive HOBSCOTCH-V (above) following a 6 month wait period.

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Dartmouth-Hitchcock Medical Center Lebanon, NH

Who Is Running the Clinical Trial?

Dartmouth-Hitchcock Medical Center Lead Sponsor

Centers for Disease Control and Prevention Collaborator

References